Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

Por Hainsworth, John D
Publicado em 2003

Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications

Por Hainsworth, John D., Anthony Greco, F.
Publicado no Drugs Real World Outcomes (2016)

High-Dose Etoposide: From Phase I to a Component of Curative Therapy

Por Wolff, Steven N., Hainsworth, John D., Greco, F. Anthony
Publicado em 2008

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

Por Greco, F. Anthony, Spigel, David R., Yardley, Denise A., Erlander, Mark G., Ma, Xiao-Jun, Hainsworth, John D.
Publicado em 2010

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, place...

Por Herbst, Roy S, Ansari, Rafat, Bustin, Frederique, Flynn, Patrick, Hart, Lowell, Otterson, Gregory A, Vlahovic, Gordana, Soh, Chang-Heok, O’Connor, Paula, Hainsworth, John
Publicado em 2011

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Por Berdeja, Jesus G., Hart, Lowell L., Mace, Joseph R., Arrowsmith, Edward R., Essell, James H., Owera, Rami S., Hainsworth, John D., Flinn, Ian W.
Publicado no Haematologica (2015)

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Canno...

Por Hainsworth, John D, Thompson, Dana S, Bismayer, John A, Gian, Victor G, Merritt, William M, Whorf, Robert C, Finney, Lindsey H, Dudley, B Stephens
Publicado no Cancer Med (2015)

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

Por Wagner-Johnston, Nina D., Link, Brian K., Byrtek, Michelle, Dawson, Keith L., Hainsworth, John, Flowers, Christopher R., Friedberg, Jonathan W., Bartlett, Nancy L.
Publicado no Blood (2015)

Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study

Por Friedberg, Jonathan W., Byrtek, Michelle, Link, Brian K., Flowers, Christopher, Taylor, Michael, Hainsworth, John, Cerhan, James R., Zelenetz, Andrew D., Hirata, Jamie, Miller, Thomas P.
Publicado em 2012

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

Por Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
Publicado no Endocr Relat Cancer (2015)

A randomized non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castrat...

Por Hussain, Maha, Rathkopf, Dana, Liu, Glenn, Armstrong, Andrew, Kelly, Wm. Kevin, Ferrari, Anna, Hainsworth, John, Joshi, Adarsh, Hozak, Rebecca R., Yang, Ling, Schwartz, Jonathan D., Higano, Celestia S.
Publicado no Eur J Cancer (2015)

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial

Por Infante, Jeffrey R., Arkenau, Hendrik-Tobias, Bendell, Johanna C., Rubin, Mark S., Waterhouse, David, Jones, George Tripp, Spigel, David R., Lane, Cassie M., Hainsworth, John D., Burris III, Howard A.
Publicado em 2013

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the N...

Por Casulo, Carla, Byrtek, Michelle, Dawson, Keith L., Zhou, Xiaolei, Farber, Charles M., Flowers, Christopher R., Hainsworth, John D., Maurer, Matthew J., Cerhan, James R., Link, Brian K., Zelenetz, Andrew D., Friedberg, Jonathan W.
Publicado no J Clin Oncol (2015)

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

Por Friedberg, Jonathan W., Taylor, Michael D., Cerhan, James R., Flowers, Christopher R., Dillon, Hildy, Farber, Charles M., Rogers, Eric S., Hainsworth, John D., Wong, Elaine K., Vose, Julie M., Zelenetz, Andrew D., Link, Brian K.
Publicado em 2009

A Single-Arm, Open-Label, Expanded Access Study of Vemurafenib in Patients With Metastatic Melanoma in the United States

Por Flaherty, Lawrence, Hamid, Omid, Linette, Gerald, Schuchter, Lynn, Hallmeyer, Sigrun, Gonzalez, Rene, Cowey, C. Lance, Pavlick, Anna, Kudrik, Fred, Curti, Brendan, Lawson, David, Chapman, Paul B., Margolin, Kim, Ribas, Antoni, McDermott, David, Flaherty, Keith, Cranmer, Lee, Hodi, F. Stephen, Day, Bann-Mo, Linke, Rolf, Hainsworth, John
Publicado no Cancer J (2014)

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Por Sekulic, Aleksandar, Migden, Michael R., Oro, Anthony E., Dirix, Luc, Lewis, Karl D., Hainsworth, John D., Solomon, James A., Yoo, Simon, Arron, Sarah T., Friedlander, Philip A., Marmur, Ellen, Rudin, Charles M., Chang, Anne Lynn S., Low, Jennifer A., Mackey, Howard M., Yauch, Robert L., Graham, Richard A., Reddy, Josina C., Hauschild, Axel
Publicado no N Engl J Med (2012)

Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA...

Por Saad, Fred, Shore, Neal, Van Poppel, Hendrik, Rathkopf, Dana E., Smith, Matthew R., de Bono, Johann S., Logothetis, Christopher J., de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A., Mainwaring, Paul, Hainsworth, John D., Beer, Tomasz M., North, Scott, Fradet, Yves, Griffin, Thomas A., De Porre, Peter, Londhe, Anil, Kheoh, Thian, Small, Eric J., Scher, Howard I., Molina, Arturo, Ryan, Charles J.
Publicado no Eur Urol (2015)

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Por de Bono, Johann S., Logothetis, Christopher J., Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N., Jones, Robert J., Goodman, Oscar B., Saad, Fred, Staffurth, John N., Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W., Hutson, Thomas E., Cheng, Tina, Patterson, Helen, Hainsworth, John D., Ryan, Charles J., Sternberg, Cora N., Ellard, Susan L., Fléhon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M., Scher, Howard I.
Publicado em 2011

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

Por Rathkopf, Dana E., Smith, Matthew R., de Bono, Johann S., Logothetis, Christopher J., Shore, Neal D., de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A., Mainwaring, Paul, Hainsworth, John D., Beer, Tomasz M., North, Scott, Fradet, Yves, Van Poppel, Hendrik, Carles, Joan, Flaig, Thomas W., Efstathiou, Eleni, Yu, Evan Y., Higano, Celestia S., Taplin, Mary-Ellen, Griffin, Thomas W., Todd, Mary, Yu, Margaret, Park, Youn C., Kheoh, Thian, Small, Eric J., Scher, Howard I., Molina, Arturo, Ryan, Charles J., Saad, Fred
Publicado no Eur Urol (2014)